Literature DB >> 11169439

Effects of cholera toxin on macrophage production of co-stimulatory cytokines.

Y Cong1, A O Oliver, C O Elson.   

Abstract

Cholera toxin (CT), the enterotoxin of Vibrio cholerae, is a potent mucosal and systemic immunogen and adjuvant. The precise mechanism of the adjuvanticity of CT is poorly understood. Our previous work has showed that CT up-regulates B7.2, but not B7.1 expression on macrophages, and thus increases their co-stimulatory activity. In the current study, the effects of CT on macrophage co-stimulatory cytokine production were investigated. Bone marrow macrophages were generated by culturing bone marrow cells with macrophage colony-stimulating factor. CT treatment increased endotoxin-stimulated macrophage IL-10, IL-6, and IL-1beta production, whereas it decreased IL-12, TNF-alpha and nitric oxide production. Antibody blocking experiments showed that CT inhibition of IL-12 and TNF-alpha production was mediated by increased IL-10 production, in that addition of anti-IL-10 monoclonal antibody abrogated CT inhibition. The decrease in nitric oxide production was in turn secondary to inhibition of TNF-alpha production. Taken together, our study demonstrated that CT has differential effects on various macrophage co-stimulatory cytokines, effects that are likely to contribute to its adjuvanticity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169439     DOI: 10.1002/1521-4141(200101)31:1<64::aid-immu64>3.0.co;2-p

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.

Authors:  Aletta C Schnitzler; Jennifer M Burke; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

Review 2.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

3.  Gut T cell receptor-γδ(+) intraepithelial lymphocytes are activated selectively by cholera toxin to break oral tolerance in mice.

Authors:  C P Frossard; K E Asigbetse; D Burger; P A Eigenmann
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

4.  Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection.

Authors:  Jessica Queen; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

5.  Promotion of colonization and virulence by cholera toxin is dependent on neutrophils.

Authors:  Jessica Queen; Karla J F Satchell
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

Review 6.  The route less taken: pulmonary models of enteric Gram-negative infection.

Authors:  Michael L Fisher; Wei Sun; Roy Curtiss
Journal:  Pathog Dis       Date:  2013-11-21       Impact factor: 3.166

7.  Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer.

Authors:  Michael Doulberis; Katerina Angelopoulou; Eleni Kaldrymidou; Anastasia Tsingotjidou; Zaphiris Abas; Suzan E Erdman; Theofilos Poutahidis
Journal:  Carcinogenesis       Date:  2014-12-30       Impact factor: 4.944

8.  Cnr2 deficiency confers resistance to inflammation-induced preterm birth in mice.

Authors:  Xiaofei Sun; Monica Cappelletti; Yingju Li; Christopher L Karp; Senad Divanovic; Sudhansu K Dey
Journal:  Endocrinology       Date:  2014-07-22       Impact factor: 4.736

9.  Decreased potency of the Vibrio cholerae sheathed flagellum to trigger host innate immunity.

Authors:  Sang Sun Yoon; John J Mekalanos
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

10.  Role of B7 costimulatory molecules in immune responses and T-helper cell differentiation in response to recombinant HagB from Porphyromonas gingivalis.

Authors:  Ping Zhang; Michael Martin; Qiu-Bo Yang; Suzanne M Michalek; Jannet Katz
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.